Press Releases
CiToxLAB increases inhalation test capabilities in North America and Europe
CiToxLAB, a leading CRO in the field of non-clinical research, announces today that it has increased its inhalation test capabilities in North America and Europe. The demand for studies to assess the safety of pharmaceuticals and chemicals via...
Press Releases
Almac expands in US with addition of Commercial Packaging facility in Almac Group
Having identified a business need in the US for a flexible and high quality commercial packaging service provider, the Pharma Services business unit of Almac is proud to expand its established commercial packaging operations with a $10m investment...
Press Releases
Pharmaceutical regulatory affairs specialist ELC Group opens new office in Mumbai
ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, today announces that it has opened a new office in Mumbai, India. The Mumbai operation will be staffed with a senior regulatory affairs team and expands ELC Group’s presence in...
Press Releases
ELC Group expands India presence with new operation at heart of world’s largest pharmaceutical hub
ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, today announces that it has opened a new office in Mumbai, India. The Mumbai operation will be staffed with a senior regulatory affairs team and expands ELC Group’s presence in India,...
Press Releases
BioCity Scotland joins forces with Harrison Goddard Foote
BioCity Scotland, the newly-opened life sciences cluster in Newhouse, Lanarkshire, has signed a three-year agreement with leading patent attorneys HGF making them the first corporate partner to join the BioCity team. The two organisations share a...
Press Releases
BHMS Investments Acquires Osmotics
BHMS Investments, LP, through affiliated funds, completed the acquisition of Osmotics Corporation , a boutique producer of science-based anti-aging skincare products. Osmotics is an industry leader in the advanced skincare market or cosmeceuticals, which it helped pioneer upon...
Press Releases
European Commission approves Esmya® for the pre-operative treatment of uterine fibroids
Gedeon Richter Plc. announced today that the European Commission has granted marketing authorization to Esmya® 5mg tablet as pre-operative treatment of moderate to severe symptoms of uterine fibroids. This decision follows positive opinion from...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read